ARCHIVES

Three Institutes To Test BioMicro’s Microarray Product. GlycoDesign Allowed Patent For Cancer Drug GD0039.

This article is from The Cancer Letter archive.

Vol. 28 No. 09 | March 1, 2002

Download PDF Visit The Full Archive

Related Articles

Reviewers Report Progress In New Drug Prescreen System Development, Commend DTP

December 15, 1989

GAO Probes NCI Intramural Program, Finds All Is Well, But Won’t Report It

October 22, 1982

Community Cancer Centers Selected For Pilot Program.

June 22, 2007

Review Guidelines For Comprehensive Centers Drafted, NCAB To Consider at December Meeting

November 24, 1989

NIH, Lasker Foundation Offer Clinical Research Opportunity

December 10, 2010

Interview: Extramural Programs Need Coordination, Klausner Says

July 25, 1997